Santen

Important update to our followers! As part of our continuous efforts to enhance your experience and streamline our communications, we have some exciting news to share. Very soon our company pages Santen and Santen Pharmaceutical will be consolidated, forming a unified and stronger presence on LinkedIn. This means that after consolidation of these two accounts, the Santen Pharmaceutical account will cease to exist. The purpose of this change into one global account is to provide you with a consolidated and cohesive source of information about our company. We look forward to having you as part of our expanded community, so don’t forget to follow the new page, Santen, from December 2024. #Santen #Merge #Update #SantenCommunity

At Santen Spain, we are proud to support training future guide dogs through our collaboration with the ONCE Guide Dog Foundation. Our Madrid office has welcomed Italica and Keira, two black labrador puppies, fostered by our colleagues, Eugenia de Plasencia Garcia and Pedro Miguel Castellanos. Spending time in the office helps the puppies develop crucial skills in diverse environments. Fernando Alvarez, General Manager Iberia, who supports the initiative stated “The company's support of programs like guide dog training reflects its dedication to helping make a difference in the lives of patients and their families. By allowing Italica and Keira to accompany their owners to the office, Santen not only fosters a positive work environment but also contributes to the training of a future service animal.” The initiative aligns with Santen’s mission in eye health and commitment to inclusion. We are excited to see Italica and Keira continue their journey towards becoming guide dogs! #SantenInspired #GuideDogs #Inclusion

Online News Site, OVO, powered by Kyodo News (Japan’s leading news agency) has published an interview with Santen employee, Mohamed Omer Abdin, Core Principle & CSV* group member. Abdin, a visually impaired Sudanese national, is committed to supporting people living with conditions similar to his. During the interview, he discussed his work with Santen, which seeks to build a society that is inclusive to all regardless of visual impairment. Please click the link below to read the full article: https://lnkd.in/eb8umbV7 (Japanese only - posted on 9 October 2024). *CSV – Creating Shared Value.

We are happy to announce the publication of Santen Report 2024, our Integrated Report for the fiscal year ending March 31, 2024. Santen’s mission is to continue to provide new value to patients and society through products and services that leverage our expertise in the field of ophthalmology and are created from the perspective of patients. We hope this year’s report will help you understand both our business and our approach to sustainability.   For the full report, please visit: English: https://lnkd.in/dudR6-hx Japanese: https://lnkd.in/djhJCawF

This #WorldSightDay, Santen recognizes the importance of helping ensure that every child has access to eye care. Common eye conditions such as myopia are often overlooked but can profoundly impact a child's education and development. By collaborating with the scientific community, patient representatives, and other key stakeholders, we are committed to elevating awareness and addressing the growing eye health challenges facing children today.   Let’s create a world where every child can see a brighter tomorrow—with accessible, affordable, and available eye care for all. Find out more: https://lnkd.in/eNGA4Dz3

Embracing our commitment to inclusion, Santen is excited to announce today our corporate volunteer partnership with Be My Eyes, the access technology provider for people who are blind or have low vision, on World Sight Day 2024. * Be My Eyes provides a free application that uses video calls to provide assistance from sighted volunteers to people who are blind or have low vision. This corporate volunteer partnership will see Santen employees in about 40 countries or regions responding to video calls from Be My Eyes users who are blind or have low vision via the Be My Eyes app on October 10. Santen employees anywhere in the world can volunteer from 8 a.m. to 9 p.m. that day. More details about the partnership can be found here: English: https://lnkd.in/dWphKgN7 Japanese: https://lnkd.in/d-NVtDW2 Learn more about Be My Eyes here: English: https://www.bemyeyes.com Japanese: https://lnkd.in/dbT6XSkq * World Sight Day is an annual initiative led by the International Agency for the Prevention of Blindness (IAPB).

[Santen “Our Stories”] Global Risk Management that Supports Sustainable Growth - Managing Third-Party Due Diligence at Santen   Santen has introduced a globally unified “Third Party Due Diligence Program” to enhance transparency and compliance adherence in its global operations. The program aims to build sustainable business partnerships by conducting thorough background screening on business partners and reducing the risk of bribery and corruption.   In this edition of “Our Stories”, Robert Van Leer, Vice President, Legal & Compliance, Global Head of Compliance and Mayumi Yamada, Manager, Legal & Compliance, Global Compliance, discuss the program purpose and outline, the passion and enthusiasm they have for the project, and the challenges experienced while implementing the program.   For the full story, please visit: Japanese article: https://lnkd.in/dy9DEXK9. English article: https://lnkd.in/dgYXQHVq.

[Santen “Our Stories”] Santen Focusing on Global Eye Health Challenges   While eye health and vision are factors that can have a major impact on our day-to-day lives, increasingly millions of people around the world face severe challenges due to visual impairments.   This edition of “Our Stories” focuses on the importance of eye health and the current situation for people suffering from eye problems. Here are some of the featured key facts:   - There are approximately, 1 billion people with treatable and preventable visual impairments1. - It is assumed that 90% of blind people worldwide suffer vision loss due to refractive error, cataracts, or other causes that can be prevented or treated2. - Visual impairment poses a serious problem from a socio-economic perspective, with an estimated global annual productivity cost of US$411 billion3.   For the full story, please visit: Japanese article: https://lnkd.in/djwzFsYG. English article: https://lnkd.in/dmNQndqi.   References 1. WHO, World report on vision October 8, 2019 https://lnkd.in/dTZ8HwC. 2. Vision Atlas - The International Agency for the Prevention of Blindness (iapb.org) https://lnkd.in/ehQheQr. 3. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.

‘Seeds of Medicine’ for Future Treatments: Santen’s Ophthalmic Innovation Center Building on its strong expertise in ophthalmology, Santen seeks to continue to deliver a broad range of treatment options through its therapeutics and services to address the unmet needs of patients and physicians. Currently, the company has a robust portfolio of more than 70 products covering an extensive range of ophthalmic diseases, while offering its products in more than 60 countries and regions. Santen’s Ophthalmology Innovation Center (OIC) is responsible for formulating and implementing disease area strategies that form the basis for the development of new drugs that support the product portfolio. “We are confident that our activities, guided by the desire to contribute to patients around the globe who suffer from eye problems, will make significant contributions to worldwide ophthalmic care in the future,” says Reza Haque, Head of the Ophthalmology Innovation Center. ‘Our Stories’ introduces OIC’s vision and the challenges it faces in pursuit of innovations that can meet the wide-ranging needs of patients suffering from eye diseases. Image features: Reza Haque, MD, Ph.D. Corporate Officer, Head, Ophthalmology Innovation Center

The Santen team is attending the International Council of Ophthalmology’s 39th World Ophthalmology Congress! Looking forward to connecting with others in the #Ophthalmology community to discuss all things #EyeCare.    #WOC2024